THE MECCC AND ITS BUSINESS DRIVERS

Over the last two decades, medical science has made significant progress in understanding the molecular mechanisms involved in the progression of cancer, and this progress has been accompanied by the development of new and more effective treatments. Yet the way in which cancer care is delivered and coordinated has by and large remained the same. Once diagnosed with cancer, most patients receive their care in a linear fashion.